ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "primary care"

  • Abstract Number: 2326 • ACR Convergence 2024

    Development and Evaluation of a Machine Learning Model for the Early Identification of Psoriatic Arthritis

    Michael Dreyfuss1, Dan Riesel2, Guy Shalev2, Benjamin Getz3, Or Ramni2, Yonatan Jenudi4, Dimid Duchovny2, Daniel Underberger5, Shlomit Steinberg-Koch2, Douglas White6 and Elena Myasoedova7, 1Predicta Med, Ramat Gan, Israel, 2Predicta Med Analytics Ltd., Ramat Gan, Israel, 3CTO, Ramat Gan, Israel, 4[email protected], Ramat Gan, Israel, 5Predicta Med Analytics Ltd., Bridgeport, CT, 6Gundersen Health System, Onalaska, WI, 7Mayo Clinic, Rochester, MN

    Background/Purpose: Delays in diagnosis of psoriatic arthritis (PsA) are associated with indolent and non-specific signs and symptoms, and often result in physical impairment and poorer…
  • Abstract Number: 0134 • ACR Convergence 2024

    Use of Oral Contraceptives in Females with Rheumatoid Arthritis Is Not Associated with an Increased Risk of Venous Thromboembolism: United Kingdom-population Based Study

    James Galloway1, Victoria Basey2, Anna Barkaway3, Simon de Lusignan4 and Maya H. Buch5, 1Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 2Pfizer UK, Tadworth, United Kingdom, 3Pfizer, Tadworth, United Kingdom, 4Royal College of General Practitioners Research and Surveillance Centre, Oxford, United Kingdom, 5Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: While the use of oral contraceptives in females with immune mediated inflammatory diseases such as rheumatoid arthritis (RA) is acknowledged as a risk factor…
  • Abstract Number: 0135 • ACR Convergence 2024

    Rheumatoid Arthritis Associated Risk of Venous Thromboembolism Is Not Dependent on Disease Duration: United Kingdom Based Population Study

    James Galloway1, Victoria Basey2, Saqib Rana3, Simon de Lusignan4 and Maya H. Buch5, 1Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 2Pfizer UK, Tadworth, United Kingdom, 3Pfizer, Tadworth, United Kingdom, 4Royal College of General Practitioners Research and Surveillance Centre, Oxford, United Kingdom, 5Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: Risk of venous thromboembolism (VTE) is higher in patients with rheumatoid arthritis (RA) compared to the general population; however whether this risk changes with…
  • Abstract Number: 0191 • ACR Convergence 2024

    Beyond the Symptoms: Exploring Cognitive Bias in Lupus Diagnosis Within Primary Care

    Alyssa Howren1, Quan Le Tran1, Sadaf Sediqi1, Saadiya Hawa2, Eleni Linos1, Titilola Falasinnu3, Yashaar Chaichian1 and Julia Simard1, 1Stanford School of Medicine, Stanford, CA, 2Weiss Memorial Hospital, Chicago, IL, 3Stanford School of Medicine, Palo Alto, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune rheumatic disease whose prognosis varies by race and sex. To understand whether the cognitive processes of…
  • Abstract Number: 0206 • ACR Convergence 2024

    Urate Lowering Therapy to Acute Treatment Ratio (ULTrA) Index – a Novel Quality Indicator Associated with Reduced Hospital Admissions for Gout

    May Shuen Tang, Frank Sen Hee Tay, Amelia Santosa, Shikha Kumari, Pamela Lim, Htet Htet Aung, Su Zin Thinn, Peter Cheung and Manjari Lahiri, National University Hospital, Singapore, Singapore

    Background/Purpose: Gout is sub-optimally managed with under-prescribed urate lowering therapy (ULT) leading to frequent flares, increased healthcare utilization and cost.To study the burden of gout…
  • Abstract Number: 0352 • ACR Convergence 2024

    Fast-tracking Axial Spondyloarthritis Diagnosis: A Novel Approach to Public Health Advocacy and Awareness

    Joe Eddison, National Axial Spondyloarthritis Society, London, United Kingdom

    Background/Purpose: The Act on Axial SpA campaign is dedicated to minimising the lengthy 8.5-year delay in diagnosing axial spondyloarthritis (axial SpA) by implementing a pioneering…
  • Abstract Number: 0547 • ACR Convergence 2024

    EspANDE Project: Improvement of Primary Care-Rheumatology Coordination in Spondyloarthritis in a Health Area in Northern Spain

    Julio Sánchez-Martín1, Cristina Martinez-Dubois2, Javier Rueda Gotor3, Gabriel Pinedo-Lopez2, Alvaro Perez-Martin2, Roberto Gonzalez-Santamaria2, Belén Atienza-Mateo4, Vanesa Calvo-Rio5, Inigo Gonzalez-Mazon6, Natalia Palmou Fontana4, Enriqueta Peiro-Callizo2, Diana Prieto-Peña4, Lara Sanchez Bilbao7, Fernando Lopez-Gutierrez8 and Ricardo Blanco-Alonso9, 1Hospital Universitario 12 de Octubre, Madrid, Spain, 2Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 3Hospital Sierrallana, Torrelavega, Cantabria, Spain, 4Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Cantabria, Spain, 5Valdecilla Hospital, Santander, Cantabria, Spain, 6H. U. Marques de Valdecilla, Santander, Cantabria, Spain, 7Rheumatology and Ophthalmology. Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 8Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 9Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Spondyloarthritis (SpA) constitutes a diverse set of inflammatory rheumatic diseases with a prevalence of 1.9% in the general population. Diagnostic delay, identified as a…
  • Abstract Number: 1079 • ACR Convergence 2024

    Early Recognition of Myositis: Time Correlation Between Transaminases and Inflammatory Myopathy in a Community-Based Rheumatology Practice

    Anjali nidhaan, Shannon Iriza, Abbie West, Michael martin and Gauri Pethe, prisma health, columbia, SC

    Background/Purpose: Recognizing muscle breakdown as a potential cause of elevated transaminases is crucial in the primary care setting to facilitate early referral to rheumatology for…
  • Abstract Number: 1213 • ACR Convergence 2024

    High Prevalence of and Medication Use in Musculoskeletal and Chronic Multisite Pain in Community-Dwelling Older Adults: The Framingham Heart Study

    Sayali Dhamne1, Robert Edwards2, Emelia Benjamin3, Sarah Tilley3, Angelo Demalia4, Margaret Clancy3, Mary Molly Gheller3 and Tuhina Neogi3, 1Boston University Chobantian & Avedisian School of Medicine, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 4Framingham Heart Study, Boston, MA

    Background/Purpose: Over 100 million adults have chronic pain, largely affecting older adults who often have >1 chronic pain condition. Traditionally, chronic overlapping pain conditions (COPC)…
  • Abstract Number: 1291 • ACR Convergence 2024

    A Needs Assessment to Inform the Design of a Musculoskeletal Ultrasound Curriculum for Internal Medicine Residents

    Ann Cameron Barr1, David Leverenz1, Lisa Criscione-Schreiber2 and Philip Chu3, 1Duke University, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3Duke University Hospital, Raleigh, NC

    Background/Purpose: Point-Of-Care Ultrasound (POCUS) training is increasingly integrated into internal medicine (IM) residency training. However, POCUS programs often focus on cardiac and peripheral line skills…
  • Abstract Number: 1295 • ACR Convergence 2024

    A Qualitative Survey of Internal Medicine Residents’ Understanding of Appropriate ANA Testing: An 11-Year Update Since the ‘Choosing Wisely’ Campaign

    Arushika Yedla1, Wei Tang2, Jaspreet Bhatti2, Kyu-In Lee3 and James Miceli3, 1Westchester Medical Center, White Plains, NY, 2Westchester Medical Center, Valhalla, 3Westchester Medical Center, Valhalla, NY

    Background/Purpose: ANA testing is recommended when there is a reasonable clinical suspicion for systemic autoimmune disease. Testing in the setting of low pre-test probability, however,…
  • Abstract Number: 1536 • ACR Convergence 2024

    Prescription Rates of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Lupus Nephritis: A Comparative Study Across Specialties

    JM JANSZ1, EA Troy2, WL Galanter3, Elaine Adams4, Nadera Sweiss5 and HJ CHANG6, 1University of Illinois at Chicago, Chicago, IL, 2University of Illinois at Chicago, Woodridge, IL, 3University of Illinois at Chicago; Jesse Brown VA Medical Center, CHICAGO, IL, 4Jesse Brown VA Medical Center, La Grange, IL, 5University of IL, Chicago, IL, 6RHEUMATOLOGIST, CHICAGO, IL

    Background/Purpose: Lupus nephritis is a well-known and severe complication in patients with systemic lupus erythematosus (SLE) that can lead to significant morbidity and mortality. Angiotensin-converting…
  • Abstract Number: 1351 • ACR Convergence 2023

    HPV Vaccination in Adolescent and Young Adult Patients Seen in an Academic Rheumatology Center

    Caroline Siegel1, Lauren Robinson1, Deanna Jannat-Khah1, Avi Mikhaylov1, Nancy Pan1 and Lisa Sammaritano2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Adolescent and young adults (AYAs) with rheumatic disease (RD) may face disproportionate risk of HPV and associated cancers due to immune dysregulation, immunosuppression and…
  • Abstract Number: 1819 • ACR Convergence 2023

    Clinical Indications Associated with New Opioid Use for Pain Management in the United Kingdom Using National Primary Care Data

    Max Lyon, Carlos Ramirez Medina, Elinor Davies and Meghna Jani, Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Prescription opioids for non-cancer pain in the UK have increased considerably over the past two decades, alongside a rise in associated harms. Despite the…
  • Abstract Number: 1848 • ACR Convergence 2023

    Demographic and Clinical Factors Associated with HPV Vaccination in Young Adults with Rheumatic Disease

    Caroline Siegel1, Lauren Robinson1, Deanna Jannat-Khah1, Avi Mikhaylov1, Nancy Pan1 and Lisa Sammaritano2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: The HPV vaccine is safe and immunogenic in RD patients but uptake is suboptimal. We aimed to evaluate factors associated with HPV vaccination in…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology